An eyewitness to the fatal shooting of a woman in Minneapolis by a federal agent on Wednesday told Newsweek that her blood was visible on the snowy ground. Speaking in the hours after the incident in ...

Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...

Federal and local officials said the man, an immigrant from Portugal, tried to flee and harm agents. He and another man were hospitalized after a vehicle they were in crashed. By Jazmine Ulloa and ...

A traffic stop outside of Baltimore Wednesday ended with an undocumented man shot and another injured after US Immigration and Customs Enforcement agents allege the driver of a van drove directly at ...

Police returned fire, striking the suspect multiple times and killing him. Three police officers in Rochester, New York, were shot Friday night "without warning at close range" while responding to a ...

Judge in Depo-Provera MDL Orders Additional Briefing on FDA's Brain Tumor Warning At a Friday hearing, U.S. District Judge M. Casey Rodgers, of the Northern District of Florida, ordered supplemental ...

Depo Provera: The Food and Drug Administration approved a label change on Friday for Pfizer’s birth control injection, Depo-Provera, alerting patients to the risk of meningioma, a tumor that develops ...

The U.S. Food and Drug Administration (FDA) approved a new safety warning for Depo-Provera, a widely used birth control shot made by Pfizer, alerting patients to a possible risk for a type of brain ...

The FDA has approved a label change on the long-acting injectable contraceptive depot medroxyprogesterone acetate, commonly known as Depo-Provera, to warn users of a potential risk of meningioma. The ...

The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...

The FDA approved a label change for Pfizer’s birth control injection Depo-Provera on Dec. 13, adding a warning about the risk of meningioma — a brain tumor — to two versions of the drug. The update ...